GNRH ANTAGONIST
Clinical trials for GNRH ANTAGONIST explained in plain language.
Never miss a new study
Get alerted when new GNRH ANTAGONIST trials appear
Sign up with your email to follow new studies for GNRH ANTAGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New prostate cancer drug aims to block hormones and slow disease
Disease control Not yet recruitingThis study tests a new drug called teverelix DP in 40 men with advanced prostate cancer. The goal is to see if it can safely lower testosterone to castrate levels, which can help control the cancer. Participants receive injections on the first day and then every six weeks. The re…
Matched conditions: GNRH ANTAGONIST
Phase: PHASE2 • Sponsor: Antev Ltd. • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
New IVF study aims to boost healthy embryo rates in PCOS patients
Knowledge-focused Not yet recruitingThis study compares two hormone treatments (PPOS and GnRH antagonist) used during IVF in women with polycystic ovary syndrome (PCOS). The goal is to see which method leads to more genetically normal embryos. About 204 women aged 20-37 will participate, and the results may help im…
Matched conditions: GNRH ANTAGONIST
Phase: PHASE3 • Sponsor: ShangHai Ji Ai Genetics & IVF Institute • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC